Women in midlife carry a heavier arthritis burden than men the same age — but men in that same age bracket have higher rates of both diabetes and coronary heart disease. The chronic disease picture for women aged 45–64 is more complicated than the standard narrative suggests.

Key Numbers

• Women aged 45–64 have an arthritis prevalence of 36%, versus 27.9% for men — a gap of 8.1 percentage points
• Men aged 45–64 have a diabetes prevalence of 16%, compared to 13.9% for women — men run 2.1 points higher
• Men's coronary heart disease (CHD) rate is 5.4% versus 3.5% for women — a 54% higher relative rate among men
• Among women aged 55–64, obesity prevalence reached 34.1% in 2014 and held near that level through 2017, consistently outpacing younger age groups
• Women aged 18–24 had an obesity rate of just 15.9% in 2014 — less than half the rate of women aged 55–64 that same year

Arthritis Is the Dominant Chronic Condition for Midlife Women — By a Wide Margin

Arthritis is where the sex gap flips decisively in women's direction. At 36% prevalence among women aged 45–64, it dwarfs both diabetes (13.9%) and CHD (3.5%) as a chronic condition burden in this group. Men in the same age range report arthritis at 27.9% — still high, but 8 points lower.

That 8.1-percentage-point gap represents a substantial difference in population-level burden. The weighted sample sizes here are large — over 785,000 women and 638,000 men — so this is not a sampling artifact. Arthritis in midlife is disproportionately a women's condition, at least by self-report.

The contrast with cardiovascular disease is stark. Men aged 45–64 have a CHD rate 54% higher than women (5.4% vs. 3.5%). On diabetes, men also lead: 16% versus 13.9%. So the answer to whether women have "higher rates of chronic disease" in midlife depends entirely on which disease you're asking about.

Men Lead on Cardiometabolic Conditions, but the Obesity Trend Narrows the Gap Over Time

The male advantage in cardiometabolic outcomes — lower diabetes and CHD rates among women aged 45–64 — sits alongside an obesity trend that warrants attention. Women aged 55–64 had obesity rates of 34.1% in 2014, 32.8% in 2015, 34.0% in 2016, and 34.0% in 2017. That's a plateau near the one-third mark, not a decline.

The 45–54 group shows the sharpest climb: from 32.4% in 2014 to 35.0% in 2017 — a 2.6-point rise in three years. Women aged 18–24 also rose, from 15.9% to 17.5%, but from a much lower base. The gradient across age groups is steep and consistent: each older cohort carries a higher obesity burden than the one below it, every year in the data.

The Age Gradient in Women's Obesity Is Steeper Than the Headlines Suggest

The raw spread between youngest and oldest women is striking. In 2014, women aged 18–24 had an obesity rate of 15.9%; women aged 55–64 had 34.1% — a 18.2-percentage-point gap within the same sex and the same survey year. By 2017, women aged 18–24 were at 17.5% and women aged 55–64 were at 34.0%, a gap of 16.5 points.

The 25–34 group moved from 28.4% in 2014 to 29.7% in 2017. The 35–44 group went from 31.7% to 33.1%. The progression is nearly monotonic: each decade of age adds roughly 2–3 percentage points of obesity prevalence among women, at least through age 64. This gradient holds across all four years in the data.

What this means for the cardiometabolic numbers is an open empirical question. Women aged 45–64 currently show lower diabetes and CHD rates than men the same age — but they're entering that window with higher obesity rates than prior cohorts did.

Open Questions

1. If women aged 45–54 had an obesity prevalence of 35% by 2017, what does their diabetes and CHD incidence look like in the years that follow — and does the sex gap in cardiometabolic disease narrow or close in the 65+ age group?

2. The arthritis gap between women and men (36% vs. 27.9%) is large, but BRFSS captures self-reported diagnosis — does the gap reflect true disease burden, differential healthcare-seeking behavior, or both?

3. Women aged 18–24 saw obesity rise from 15.9% in 2014 to 18.5% in 2016 before dipping to 17.5% in 2017 — is that 2016 spike a data artifact, a cohort effect, or the leading edge of a trend that continued past 2017?